Analyst Ratings For NASDAQ:KTOV – Kitov Pharma (NASDAQ:KTOV)
Today, HC Wainwright reiterated its Buy rating on NASDAQ:KTOV – Kitov Pharma (NASDAQ:KTOV) with a price target of $10.00.
Some recent analyst ratings include
- 5/14/2018-HC Wainwright Reiterated Rating of Buy.
- 7/11/2016-Rodman & Renshaw Reiterated Rating of Buy.
Recent Trading Activity for NASDAQ:KTOV – Kitov Pharma (NASDAQ:KTOV)
Shares of NASDAQ:KTOV – Kitov Pharma closed the previous trading session at 2.56 up +0.16 6.52% with shares trading hands.